AAAAAA
Results:
1-21
|
Results: 21
Authors:
Dempfle, CE
Zips, S
Ergul, H
Heene, DL
Citation: Ce. Dempfle et al., The fibrin assay comparison trial (FACT): Correlation of soluble fibrin assays with D-dimer, THROMB HAEM, 86(5), 2001, pp. 1204-1209
Authors:
Huhle, G
Liebe, V
Hudek, R
Heene, DL
Citation: G. Huhle et al., Anti-r-hirudin antibodies reveal clinical relevance through direct functional inactivation of r-hirudin or prolongation of r-hirudin's plasma halflife, THROMB HAEM, 85(5), 2001, pp. 936-938
Authors:
Dempfle, CE
Zips, S
Ergul, H
Heene, DL
Citation: Ce. Dempfle et al., The Fibrin Assay Comparison Trial (FACT) - Evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators, THROMB HAEM, 85(4), 2001, pp. 671-678
Authors:
Dempfle, CE
Burck, C
Grutzmacher, T
Wizenmann, J
Heene, DL
Citation: Ce. Dempfle et al., Increase in platelet count in response to rHuEpo in a patient with thrombocytopenia and absent radii syndrome, BLOOD, 97(7), 2001, pp. 2189-2190
Authors:
Huhle, G
Hoffmann, U
Hoffmann, I
Harenberg, J
Heene, DL
Citation: G. Huhle et al., Prevention of thrombosis with recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study, DEUT MED WO, 125(22), 2000, pp. 686-691
Authors:
Huhle, G
Geberth, M
Hoffmann, U
Heene, DL
Harenberg, J
Citation: G. Huhle et al., Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin, GYNECOL OBS, 49(1), 2000, pp. 67-69
Authors:
Stehle, G
Wunder, A
Heene, DL
Citation: G. Stehle et al., Is albumin administration harmful in critically ill patients? The patient's nitrogen and energy balance may provide an answer, CRIT CARE M, 28(5), 2000, pp. 1697-1697
Authors:
Huhle, G
Hoffmann, U
Hoffmann, I
Liebe, V
Harenberg, JF
Heene, DL
Citation: G. Huhle et al., A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: A pilot study, THROMB RES, 99(4), 2000, pp. 325-334
Authors:
Dempfle, CE
Argiriou, S
Kucher, K
Muller-Peltzer, H
Rubsamen, K
Heene, DL
Citation: Ce. Dempfle et al., Analysis of fibrin formation and proteolysis during intravenous administration of ancrod, BLOOD, 96(8), 2000, pp. 2693-2702
Authors:
Dempfle, CE
Argiriou, S
Kucher, K
Muller-Peltzer, H
Rubsamen, K
Heene, DL
Citation: Ce. Dempfle et al., Analysis of fibrin formation and proteolysis during intravenous administration of ancrod, BLOOD, 96(8), 2000, pp. 2793-2802
Authors:
Hartung, G
Stehle, G
Sinn, H
Wunder, A
Schrenk, HH
Heeger, S
Kranzle, M
Edler, L
Frei, E
Fiebig, HH
Heene, DL
Maier-Borst, W
Queisser, W
Citation: G. Hartung et al., Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients, CLIN CANC R, 5(4), 1999, pp. 753-759
Authors:
Stehle, G
Wunder, A
Schrenk, HH
Hartung, G
Heene, DL
Sinn, H
Citation: G. Stehle et al., Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate, ANTI-CANC D, 10(8), 1999, pp. 785-790
Authors:
Stehle, G
Wunder, A
Schrenk, HH
Hartung, G
Heene, DL
Sinn, H
Citation: G. Stehle et al., Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats, ANTI-CANC D, 10(4), 1999, pp. 405-411
Authors:
Muller, A
Huhle, G
Nowack, R
Birck, R
Heene, DL
van der Woude, FJ
Citation: A. Muller et al., Serious bleeding in a haemodialysis patient treated with recombinant hirudin, NEPH DIAL T, 14(10), 1999, pp. 2482-2483
Authors:
Saur, J
Zell, L
Heene, DL
Citation: J. Saur et al., Mercury embolisation of the pulmonary artery, MED KLIN, 94(9), 1999, pp. 520-521
Authors:
Dempfle, CE
Keller, A
Argirion, S
Heene, DL
Citation: Ce. Dempfle et al., A 96-well microfiltration assay for measurement of total clottable fibrinogen, THROMB HAEM, 81(2), 1999, pp. 264-267
Authors:
Kulinna, W
Ney, D
Wenzel, T
Heene, DL
Harenberg, J
Citation: W. Kulinna et al., The effect of self-monitoring the INR on quality of anticoagulation and quality of life, SEM THROMB, 25(1), 1999, pp. 123-126
Authors:
Huhle, G
Abletshauser, C
Mayer, N
Weidinger, G
Harenberg, J
Heene, DL
Citation: G. Huhle et al., Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor, THROMB RES, 95(5), 1999, pp. 229-234
Authors:
Stehle, G
Heene, DL
Wunder, A
Schrenk, HH
Sinn, H
Citation: G. Stehle et al., Direct convective macromolecule delivery, J NEUROSURG, 90(3), 1999, pp. 610-611
Authors:
Huhle, G
Hoffmann, U
Song, X
Wang, LC
Heene, DL
Harenberg, J
Citation: G. Huhle et al., Immunologic response to recombinant hirudin in HIT type II patients duringlong-term treatment, BR J HAEM, 106(1), 1999, pp. 195-201
Authors:
Stehle, G
Wunder, A
Hartung, G
Sinn, H
Heene, DL
Citation: G. Stehle et al., Prognostic value of cathepsin D in breast cancer, BR J CANC, 81(8), 1999, pp. 1427-1428
Risultati:
1-21
|